| Literature DB >> 29698416 |
Mi Kyung Lee1,2, Nam Kyu Kim2,3, Justin Y Jeon1,2,4.
Abstract
Despite improvement in prognosis of colorectal cancer, colorectal cancer survivors often suffer from adverse effects of cancer treatment, including reduced health-related fitness level. Therefore, this study aimed to examine the feasibility and efficacy of the 6-week home-based exercise program on the level of physical activity and physical fitness in stage II to III colorectal cancer survivors. Seventy-two stage II to III colorectal cancer survivors were randomly assigned to either a home-based exercise (n = 38) or usual care (n = 34) group for 6 weeks. The goal of the home-based exercise program was to increase the level of exercise to 18 metabolic equivalent task hours per week. The primary and the secondary outcomes of this study were physical activity level and physical fitness, respectively. A total of 57 participants (79.2%) completed the trial. Intention-to-treat analysis indicated that moderate physical activity level increased significantly by 269.4 ± 260.6 minutes per week in the exercise group (mean between-group difference, 254.6 minutes; 95% confidence interval, 172.7-434.7; p < 0.001). Physical fitness measured by using the step test (-3.9 vs. 2.6, p = 0.012) and push-up test (3.0 vs. -1.2, p = 0.012) also improved significantly in the exercise group compared to the control group. The 6-week home-based mixed aerobic and resistance exercise program was feasible and effective for increasing physical activity level and physical fitness in stage II to III colorectal cancer survivors.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29698416 PMCID: PMC5919699 DOI: 10.1371/journal.pone.0196220
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1CONSORT diagram.
Baseline demographics and medical profile of participants overall and by group assignment.
| Variable | Overall | Exercise | Usual care | |
|---|---|---|---|---|
| 56.3 ± 9.4 | 55.9 ± 8.8 | 56.8 ± 10.2 | 0.698 | |
| 35 (48.6) | 18 (47.4) | 17 (50.0) | 1.00 | |
| 62.9 ± 10.7 | 63.4 ± 9.0 | 62.5 ± 12.6 | 0.725 | |
| 23.5 ± 3.2 | 23.6 ± 2.9 | 23.3 ± 3.6 | 0.655 | |
| 55 (77.5) | 28 (75.7) | 27 (79.4) | 0.526 | |
| 30 (43.5) | 19 (52.8) | 11 (33.3) | 0.458 | |
| 0.537 | ||||
| | 33 (47.8) | 19 (54.3) | 14 (41.2) | |
| | 32 (46.4) | 14 (40.0) | 18 (52.9) | |
| | 4 (5.8) | 2 (5.7) | 2 (5.9) | |
| 0.223 | ||||
| | 46 (63.9) | 27 (71.1) | 19 (55.9) | |
| | 26 (36.1) | 11 (28.9) | 15 (44.1) | |
| 0.103 | ||||
| | 33 (45.8) | 21 (55.3) | 12 (35.3) | |
| | 39 (54.2) | 17 (44.7) | 22 (64.7) | |
| 0.397 | ||||
| | 58 (80.6) | 30 (78.9) | 28 (82.4) | |
| | 9 (12.5) | 4 (10.5) | 5 (14.7) | |
| 10.8 ± 7.1 | 10.9 ± 5.8 | 10.6 ± 8.4 | 0.850 |
Values are presented as mean ± SD or n (%).
Changes in physical fitness, body composition, and physical activity level in the exercise and usual care groups (n = 72).
| Variable | Exercise (n = 38) | Usual care (n = 34) | Adjusted group differences in mean change | ||||
|---|---|---|---|---|---|---|---|
| Baseline | 6 weeks | Baseline | 6 weeks | Mean | 95% CI | ||
| 92.0 ± 13.1 | 88.0 ± 13.2 | 93.0 ± 14.7 | 95.6 ± 13.6 | -7.2 | -12.8 to 1.7 | 0.012 | |
| 576.6 ± 85.5 | 585.5 ± 82.9 | 582.5 ± 70.9 | 594.3 ± 96.7 | -3.6 | -26.7 to 19.4 | 0.754 | |
| 21.1 ± 6.6 | 21.2 ± 5.2 | 24.4 ± 6.6 | 22.2 ± 5.4 | 2.0 | -0.7 to 4.7 | 0.137 | |
| 14.2 ± 9.7 | 17.2 ± 9.6 | 16.6 ± 11.8 | 15.4 ± 11.0 | 4.3 | 1.0 to 7.7 | 0.012 | |
| 63.4 ± 9.0 | 63.6 ± 8.9 | 62.5 ± 12.6 | 62.9 ± 12.6 | -0.3 | -0.8 to 0.1 | 0.174 | |
| 23.6 ± 2.9 | 23.7 ± 3.1 | 23.3 ± 3.6 | 23.5 ± 3.6 | -0.15 | -0.6 to 0.3 | 0.534 | |
| 82.7 ± 8.6 | 82.6 ± 8.2 | 81.6 ± 9.8 | 82.1 ± 10.3 | -0.8 | -1.9 to 0.4 | 0.205 | |
| 27.8 ± 8.5 | 26.8 ± 8.5 | 27.5 ± 8.2 | 27.2 ± 8.4 | -1.1 | -2.2 to 0.01 | 0.052 | |
| 0 | 20.1 ± 78.8 | 0 | 6.0 ± 24.2 | 22.3 | -9.9 to 54.6 | 0.172 | |
| 108.8 ± 196.6 | 378.2 ± 297.6 | 128.9 ± 187.0 | 143.7 ± 174.0 | 303.7 | 172.7 to 434.7 | <0.001 | |
| 190.6 ± 225.4 | 184.6 ± 222.4 | 197.7 ± 227.8 | 159.8 ± 187.0 | 24.9 | -83.9 to 133.7 | 0.649 | |
| 296.2 ± 244.1 | 571.1±382.4 | 326.5 ± 294.3 | 309.4±196.7 | 348.4 | 211.4 to 485.4 | <0.001 | |
| 16.6 ± 14.1 | 35.6 ± 25.0 | 18.5 ± 17.4 | 18.2±11.6 | 23.5 | 14.7 to 32.4 | <0.001 | |
Adjusted group difference in mean change was adjusted for baseline value of age, gender, body mass index, education level, location of tumor, tumor stage, and cancer treatment. Values are presented as mean ± SD.
*p < 0.05 difference between baseline and 6-weeks.